| 000 | 01694 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250514015850.0 | ||
| 264 | 0 | _c20020305 | |
| 008 | 200203s 0 0 eng d | ||
| 022 | _a0306-4522 | ||
| 024 | 7 |
_a10.1016/s0306-4522(01)00383-9 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aScammell, T E | |
| 245 | 0 | 0 |
_aAn adenosine A2a agonist increases sleep and induces Fos in ventrolateral preoptic neurons. _h[electronic resource] |
| 260 |
_bNeuroscience _c2001 |
||
| 300 |
_a653-63 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAdenosine _xanalogs & derivatives |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntihypertensive Agents _xpharmacology |
| 650 | 0 | 4 |
_aBrain Chemistry _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNeurons _xchemistry |
| 650 | 0 | 4 |
_aPhenethylamines _xpharmacology |
| 650 | 0 | 4 |
_aPreoptic Area _xcytology |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-fos _xanalysis |
| 650 | 0 | 4 | _aPurinergic P1 Receptor Agonists |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 | _aReceptor, Adenosine A2A |
| 650 | 0 | 4 |
_aSleep _xdrug effects |
| 650 | 0 | 4 | _aSpecific Pathogen-Free Organisms |
| 650 | 0 | 4 | _aSubarachnoid Space |
| 650 | 0 | 4 |
_aWakefulness _xdrug effects |
| 700 | 1 | _aGerashchenko, D Y | |
| 700 | 1 | _aMochizuki, T | |
| 700 | 1 | _aMcCarthy, M T | |
| 700 | 1 | _aEstabrooke, I V | |
| 700 | 1 | _aSears, C A | |
| 700 | 1 | _aSaper, C B | |
| 700 | 1 | _aUrade, Y | |
| 700 | 1 | _aHayaishi, O | |
| 773 | 0 |
_tNeuroscience _gvol. 107 _gno. 4 _gp. 653-63 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0306-4522(01)00383-9 _zAvailable from publisher's website |
| 999 |
_c11635118 _d11635118 |
||